Clinical Trials Logo

Cervical Cancer Stage IB2 clinical trials

View clinical trials related to Cervical Cancer Stage IB2.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04770090 Recruiting - Clinical trials for Cervical Cancer Stage IB1

Research of Circulating Tumor Cells Released During Cervical Cancer Surgery

CTC-COL
Start date: November 17, 2021
Phase: N/A
Study type: Interventional

Cervical cancer is a rare pathology. Recent studies showed that the risk of recurrence is higher for patients treated by coelioscopy in comparison with laparotomy. It could be explained by the spread of circulating tumor cells (CTC) due to tumor mobilization during different steps of the surgery. The primary goal is to evaluate the spread of CTC during surgery on peripheral blood samples. The secondary outcome is to evaluation the disease-free survival at 3 and 5 years postoperatively. 20 patients with early stage cervical (IA1 to IB2) eligible to coelioscopic stadification and laparoscopic surgery will be included.